Added to YB: 2024-04-12
Pitch date: 2024-04-12
SLS:US [bullish]
SELLAS Life Sciences Group, Inc.
+56.15%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States.
Market Cap
$94.5M
Pitch Price
$1.30
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.64
P/E
-2.06
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
SELLAS Life Sciences Group, Inc. SLS:US
A summary for this pitch has not been created yet.
Read full article (0 min)